Tenet Healthcare
THC
259.83
+1.36
+0.53%
Tenet Healthcare
US · THC
#905 by market cap
Listed 1970
259.83
+1.36
+0.53%
Live - 5344 symbols - heartbeat 377s ago
· 2026-10-08 07:39
Pre-market
259.83
0.00%
After-hours
259.45
-0.15%
- Market cap
- 20.92B
- P/E (TTM)i
- 10.04
- P/Bi
- 4.49
- EPSi
- 15.49
- Div yieldi
- 0.00%
- 52W posi
- 81%
Reader sentiment
Are you bullish or bearish on THC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 18 analysts
Buy
Avg price target
283.41 +9.1%
Price target rangecurrent 259.83
Low245.00
Avg283.41
High315.00
Buy 89%
Hold 11%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Raymond James | -- | BUY | 285.00 |
| 2026-09-22 | BMO Capital | -- | HOLD | 265.00 |
| 2026-09-17 | Leerink Partners | -- | BUY | -- |
| 2026-09-14 | Morgan Stanley | -- | BUY | 274.00 |
| 2026-09-01 | J.P. Morgan | -- | BUY | 315.00 |
| 2026-08-25 | UBS | -- | BUY | 308.00 |
| 2026-08-10 | Mizuho Securities | -- | BUY | 290.00 |
| 2026-08-10 | BofA Securities | -- | BUY | 295.00 |
| 2026-07-31 | Wells Fargo | -- | BUY | 281.00 |
| 2026-07-29 | Goldman Sachs | -- | BUY | 305.00 |
| 2026-07-28 | Truist Financial | -- | BUY | 290.00 |
| 2026-07-28 | Baird | -- | HOLD | 280.00 |
| 2026-07-28 | Goldman Sachs | -- | BUY | 305.00 |
| 2026-07-27 | TD Cowen | -- | BUY | 263.00 |
| 2026-07-27 | UBS | -- | BUY | 308.00 |
| 2026-07-27 | Truist Financial | -- | BUY | 270.00 |
| 2026-07-27 | Morgan Stanley | -- | BUY | 274.00 |
| 2026-07-27 | Stephens | -- | BUY | 285.00 |
| 2026-07-27 | Guggenheim | -- | BUY | 283.00 |
| 2026-07-26 | TD Cowen | -- | BUY | 263.00 |
| 2026-07-26 | RBC Capital | -- | BUY | 283.00 |
| 2026-07-24 | BofA Securities | -- | BUY | 265.00 |
| 2026-07-24 | Barclays | -- | BUY | 271.00 |
| 2026-07-23 | Cantor Fitzgerald | -- | BUY | 245.00 |
| 2026-07-20 | Guggenheim | -- | BUY | 242.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A+
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-24 | -- | ±11.24% | +17.17% (beat) |
| 2026/Q1 | 2026-04-30 | -- | ±11.24% | -1.65% (in line) |
| 2025/Q4 | 2026-02-11 | -- | ±7.77% | +17.26% (beat) |
| 2025/Q3 | 2025-10-28 | -- | ±8.25% | -5.34% (in line) |
| 2025/Q2 | 2025-07-22 | -- | ±10.77% | -10.70% (in line) |
| 2025/Q1 | 2025-04-29 | -- | ±12.56% | +11.65% (in line) |
| 2024/Q4 | 2025-02-12 | -- | ±10.31% | -9.10% (in line) |
| 2024/Q3 | 2024-10-29 | -- | ±11.12% | +16.68% (beat) |
| 2024/Q2 | 2024-07-24 | -- | ±9.27% | +4.80% (in line) |
| 2024/Q1 | 2024-04-30 | -- | ±8.69% | +13.25% (beat) |
| 2023/Q4 | 2024-02-08 | -- | ±7.87% | +1.03% (in line) |
| 2023/Q3 | 2023-10-30 | After close | ±13.70% | +0.85% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:39:15 · For reference only, not investment advice and not tailored to your situation.